MF
ADMA icon

Magnetar Financial’s ADMA Biologics ADMA Stock Holding History

Magnetar Financial’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,633
Closed -$159K – 1143
2026
Q1 		$159K Buy
+17,633
New +$278K ﹤0.01% 933
2025
Q4 		– Sell
-108,085
Closed -$1.58M – 907
2025
Q3 		$1.58M Buy
+108,085
New +$1.85M 0.01% 400
2024
Q4 		– Sell
-40,075
Closed -$801K – 594
2024
Q3 		$801K Sell
40,075
-3,672,183
-99% -$57.1M 0.02% 295
2024
Q2 		$41.5M Sell
3,712,258
-947,120
-20% -$7.95M 0.87% 41
2024
Q1 		$30.8M Sell
4,659,378
-1,623,178
-26% -$8.87M 0.69% 53
2023
Q4 		$28.4M Buy
6,282,556
+408,378
+7% +$1.51M 0.72% 44
2023
Q3 		$21M Sell
5,874,178
-161,360
-3% -$621K 0.54% 60
2023
Q2 		$22.3M Sell
6,035,538
-1,039,184
-15% -$3.85M 0.49% 66
2023
Q1 		$23.4M Buy
7,074,722
+887,406
+14% +$3.07M 0.46% 60
2022
Q4 		$24M Buy
6,187,316
+1,815,908
+42% +$5.6M 0.41% 59
2022
Q3 		$10.6M Sell
4,371,408
-2,489,464
-36% -$5.97M 0.15% 172
2022
Q2 		$13.6M Buy
6,860,872
+351,955
+5% +$692K 0.14% 142
2022
Q1 		$11.9M Sell
6,508,917
-626,031
-9% -$977K 0.13% 166
2021
Q4 		$10.1M Buy
7,134,948
+6,323,986
+780% +$8.31M 0.1% 205
2021
Q3 		$916K Buy
810,962
+204,831
+34% +$287K 0.01% 743
2021
Q2 		$970K Sell
606,131
-11,791
-2% -$20.7K 0.01% 737
2021
Q1 		$1.09M Buy
617,922
+58,410
+10% +$134K 0.01% 683
2020
Q4 		$1.09M Buy
559,512
+199,531
+55% +$419K 0.02% 449
2020
Q3 		$860K Buy
359,981
+218,458
+154% +$599K 0.02% 366
2020
Q2 		$415K Sell
141,523
-250,700
-64% -$720K 0.01% 294
2020
Q1 		$1.13M Buy
392,223
+320,000
+443% +$1.11M 0.03% 154
2019
Q4 		$289K Buy
72,223
+22,223
+44% +$96.9K 0.01% 451
2019
Q3 		$223K Buy
+50,000
New +$209K 0.01% 430

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Magnetar Financial's ADMA Position: Q2 2026 in Review

Magnetar Financial sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 17,633 shares — an estimated $159K sold.

Magnetar Financial first reported a position in ADMA in Q3 2019 and held it in 23 quarters. The position peaked at $41.5M in Q2 2024. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Magnetar Financial reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Magnetar Financial sold 17,633 ADMA Biologics shares in Q2 2026, an estimated $159K.
  • Magnetar Financial first reported a position in ADMA Biologics in Q3 2019 and held it in 23 quarters.
  • Magnetar Financial's ADMA Biologics position peaked at $41.5M in Q2 2024.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.